Alatrofloxacin Explained

Alatrofloxacin (Trovan IV) is a fluoroquinolone antibiotic developed by Pfizer, delivered as a mesylate salt.[1]

Trovafloxacin and alatrofloxacin were both withdrawn from the U.S. market in June 2006 due to hepatotoxicity leading to liver transplant or death.[2] [3]

See also

Notes and References

  1. Web site: Center for Drug Evaluation and Research Application Number: 020759/020760 Chemistry Review(s). Food and Drug Administration. 29 August 2014.
  2. Qureshi ZP, Seoane-Vazquez E, Rodriguez-Monguio R, Stevenson KB, Szeinbach SL . Market withdrawal of new molecular entities approved in the United States from 1980 to 2009 . Pharmacoepidemiology and Drug Safety . 20 . 7 . 772–777 . July 2011 . 21574210 . 10.1002/pds.2155 . 23821961 .
  3. Web site: TROVAN® Tablets(trovafloxacin mesylate)TROVAN® I.V.(alatrofloxacin mesylate injection)For Intravenous Infusion . 2024-08-03 . DailyMed.

This article is licensed under the GNU Free Documentation License. It uses material from the Wikipedia article "Alatrofloxacin".

Except where otherwise indicated, Everything.Explained.Today is © Copyright 2009-2024, A B Cryer, All Rights Reserved. Cookie policy.